Published in Hospital and Nursing Home Week, October 28th, 2004
"We hypothesized that there may be changes in the cardiovascular system of ArKO mice because of evidence linking estrogens with improved cardiovascular outcomes and the induction of the glucocorticoid-metabolizing enzyme, 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2), gene in the kidney, which is important for the regulation of blood pressure (BP)," said G.A. Head and colleagues at the Baker Heart Research Institute in Australia.
"BP and baroreflex sensitivity (BRS) in female conscious ArKO mice...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week